Symbiotec Pharmalab Ltd
NSE: SYMBIOTEC | BSE: 544889
₹1,198.00
As on 01-Oct-2026IST
Market cap
₹7,706 Cr
Revenue (TTM)
₹869 Cr
P/E Ratio
70.1
P/B Ratio
5.1
Div. Yield
0 %
Quality Score
5/10
Growth Score
8/10
Valuation Score
4/10
Momentum Score
UNRATED/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹110 Cr
-
ROE
11.2 %
-
ROCE
12.4 %
-
Industry P/E
56.89
-
EV/EBITDA
33.4
-
Debt to Equity
0.3
-
Book Value
₹183.2
-
EPS
₹17.5
-
Face value
2
-
Shares outstanding
64,256,112
8 Years Aggregate
CFO
₹625.60 Cr
EBITDA
₹868.98 Cr
Net Profit
₹443.47 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Symbiotec Pharmalab
| -- | 21.3 | -- | -- | -- | -- | -- |
|
BSE Sensex
| -15.1 | -6.6 | -6.0 | -10.4 | 3.0 | 4.0 | 9.9 |
|
BSE Healthcare
| 14.9 | -3.2 | 1.2 | 15.8 | 20.5 | 13.8 | 11.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Symbiotec Pharmalab
|
1,198.0 | 7,706.2 | 869.2 | 109.9 | -- | 11.2 | 70.1 | 5.1 |
| 1,374.2 | 16,849.2 | 2,590.4 | 603.0 | 29.3 | 19.6 | 27.9 | 4.8 | |
| 541.8 | 10,259.7 | 885.7 | 234.9 | 27.8 | 18 | 43.7 | 4.6 | |
| 1,374.1 | 14,385.3 | 1,108.4 | 270.2 | 28.3 | 14.5 | 52.2 | 6.9 | |
| 1,944.6 | 36,872.2 | 9,683.5 | 1,019.0 | 15.7 | 21.3 | 36.5 | 7.0 | |
| 133.7 | 7,326.1 | 1,950.6 | 140.6 | 7.6 | 9.6 | 52.1 | 5.6 | |
| 21,505.0 | 27,579.5 | 2,371.8 | 497.8 | 28.0 | 28.5 | 55.4 | 13.6 | |
| 990.0 | 5,937.9 | 942.6 | 9.9 | 0.3 | 1.2 | 685.2 | 3.8 | |
| 1,199.8 | 13,556.1 | 675.6 | 183.6 | 32.2 | 22.7 | 74.2 | 14.7 | |
| 308.3 | 8,717.1 | 8.8 | -352.4 | -4,228.0 | -80.8 | -- | 15.7 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsAbout Symbiotec Pharmalab
--
-
Incorporated
2002
-
Chairman
Anil Satwani
-
Managing Director
Anil Satwani
-
Headquarters
Indore, Madhya Pradesh
-
Website
Looking for more details about Symbiotec Pharmalab Ltd’s IPO? Explore our IPO Details page.
FAQs for Symbiotec Pharmalab
What is the current share price of Symbiotec Pharmalab Ltd Today?
The share price of Symbiotec Pharmalab Ltd is ₹1,198.00 (NSE) and ₹1,199.30 (BSE) as of 01-Oct-2026 IST. Symbiotec Pharmalab Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Symbiotec Pharmalab Ltd?
The P/E ratio of Symbiotec Pharmalab Ltd is 70.12 times as on 01-Oct-2026, a 23 premium to its peers’ median range of 56.89 times.
The P/B ratio of Symbiotec Pharmalab Ltd is 5.14 times as on 01-Oct-2026, a 4 premium to its peers’ median range of 4.95 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
0.00 |
0.00 |
2025 |
0.00 |
0.00 |
2024 |
0.00 |
0.00 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
What is the 52 Week High and Low of Symbiotec Pharmalab Ltd?
The 52-week high and low of Symbiotec Pharmalab Ltd are Rs 1,246.00 and Rs 934.20 as of 01-Oct-2026.
What is the market cap of Symbiotec Pharmalab Ltd?
Symbiotec Pharmalab Ltd has a market capitalisation of ₹ 7,706 Cr as on 01-Oct-2026. As per SEBI classification, it is a company.
Should I invest in Symbiotec Pharmalab Ltd?
Before investing in Symbiotec Pharmalab Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
